Literature DB >> 15168030

[Multiple endocrine neoplasia type 1. Surgical therapy of primary hyperparathyroidism].

P Langer1, A Wild, T Schilling, C Nies, M Rothmund, D K Bartsch.   

Abstract

Primary hyperparathyroidism (pHPT) occurs in about 90% of patients with multiple endocrine neoplasia type 1 (MEN1). In contrast to sporadic pHPT, multiple gland disease is most common in MEN1. The appropriate surgical approach is still controversial. The aim of this study was to analyze the results of surgical therapy of pHPT in patients with genetically confirmed MEN1. In an observational study, preoperative data, operative procedures, long-term results, and a possible genotype-phenotype correlation were analyzed in patients with pHPT and genetically confirmed MEN1. According to our results, tPTX+T (total parathyroidectomy+thymectomy+autotransplantation) seems to be a more favorable surgical approach in patients with MEN1 pHPT than sDE (selective gland exstirpation) and stPTX (subtotal parathyroidectromy) without cervical thymectomy, because recurrences or persistence of the disease are rare. A prospective randomized trial is needed to compare stPTX including cervical thymectomy vs tPTX+T. A genotype-phenotype correlation could not be identified.

Entities:  

Mesh:

Year:  2004        PMID: 15168030     DOI: 10.1007/s00104-004-0838-4

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  26 in total

Review 1.  Calcimimetics in the treatment of primary hyperparathyroidism.

Authors:  Diana M Antoniucci; Dolores Shoback
Journal:  J Bone Miner Res       Date:  2002-11       Impact factor: 6.741

Review 2.  Guidelines for diagnosis and therapy of MEN type 1 and type 2.

Authors:  M L Brandi; R F Gagel; A Angeli; J P Bilezikian; P Beck-Peccoz; C Bordi; B Conte-Devolx; A Falchetti; R G Gheri; A Libroia; C J Lips; G Lombardi; M Mannelli; F Pacini; B A Ponder; F Raue; B Skogseid; G Tamburrano; R V Thakker; N W Thompson; P Tomassetti; F Tonelli; S A Wells; S J Marx
Journal:  J Clin Endocrinol Metab       Date:  2001-12       Impact factor: 5.958

3.  Intraoperative parathormone measurement in patients with multiple endocrine neoplasia type I syndrome and hyperparathyroidism.

Authors:  F Tonelli; S Spini; M Tommasi; G Gabbrielli; A Amorosi; A Brocchi; M L Brandi
Journal:  World J Surg       Date:  2000-05       Impact factor: 3.352

4.  Adrenal involvement in multiple endocrine neoplasia type 1.

Authors:  Peter Langer; Kenko Cupisti; Detlef K Bartsch; Christoph Nies; Peter E Goretzki; Matthias Rothmund; Hans D Röher
Journal:  World J Surg       Date:  2002-05-21       Impact factor: 3.352

5.  Prospective study of the natural history of gastrinoma in patients with MEN1: definition of an aggressive and a nonaggressive form.

Authors:  F Gibril; D J Venzon; J V Ojeaburu; S Bashir; R T Jensen
Journal:  J Clin Endocrinol Metab       Date:  2001-11       Impact factor: 5.958

6.  MEN1 gene mutations in 12 MEN1 families and their associated tumors.

Authors:  D Bartsch; I Kopp; A Bergenfelz; H Rieder; K Münch; K Jäger; Y Deiss; A Schudy; P Barth; R Arnold; M Rothmund; B Simon
Journal:  Eur J Endocrinol       Date:  1998-10       Impact factor: 6.664

7.  Short-term inhibition of parathyroid hormone secretion by a calcium-receptor agonist in patients with primary hyperparathyroidism.

Authors:  S J Silverberg; H G Bone; T B Marriott; F G Locker; S Thys-Jacobs; G Dziem; S Kaatz; E L Sanguinetti; J P Bilezikian
Journal:  N Engl J Med       Date:  1997-11-20       Impact factor: 91.245

8.  Secondary hyperparathyroidism: diagnosis of site of recurrence.

Authors:  D Casanova; E Sarfati; A De Francisco; J A Amado; M Arias; C Dubost
Journal:  World J Surg       Date:  1991 Jul-Aug       Impact factor: 3.352

9.  Effect of parathyroidectomy in patients with hyperparathyroidism, Zollinger-Ellison syndrome, and multiple endocrine neoplasia type I: a prospective study.

Authors:  J A Norton; M J Cornelius; J L Doppman; P N Maton; J D Gardner; R T Jensen
Journal:  Surgery       Date:  1987-12       Impact factor: 3.982

10.  The surgical management of hyperparathyroidism and endocrine disease of the pancreas in the multiple endocrine neoplasia type 1 patient.

Authors:  N W Thompson
Journal:  J Intern Med       Date:  1995-09       Impact factor: 8.989

View more
  7 in total

1.  [Hereditary neuroendrocrine tumors. Multiple endocrine neoplasia type 1 and 2].

Authors:  A Rinke; S R Galan; V Fendrich; P H Kann; D K Bartsch; T M Gress
Journal:  Internist (Berl)       Date:  2012-04       Impact factor: 0.743

Review 2.  The optimal surgical treatment for primary hyperparathyroidism in MEN1 patients: a systematic review.

Authors:  Jennifer M J Schreinemakers; Carolina R C Pieterman; Anouk Scholten; Menno R Vriens; Gerlof D Valk; Inne H M Borel Rinkes
Journal:  World J Surg       Date:  2011-09       Impact factor: 3.352

3.  Peripheral bone mineral density in correlation to disease-related predisposing conditions in patients with multiple endocrine neoplasia type 1.

Authors:  P H Kann; D Bartsch; P Langer; J Waldmann; P Hadji; A Pfützner; J Klüsener
Journal:  J Endocrinol Invest       Date:  2011-07-27       Impact factor: 4.256

Review 4.  Less Than Subtotal Parathyroidectomy for Multiple Endocrine Neoplasia Type 1 Primary Hyperparathyroidism: A Systematic Review and Meta-Analysis.

Authors:  Damien Bouriez; Caroline Gronnier; Magalie Haissaguerre; Antoine Tabarin; Haythem Najah
Journal:  World J Surg       Date:  2022-06-29       Impact factor: 3.282

5.  Prospective study of surgery for primary hyperparathyroidism (HPT) in multiple endocrine neoplasia-type 1 and Zollinger-Ellison syndrome: long-term outcome of a more virulent form of HPT.

Authors:  Jeffrey A Norton; David J Venzon; Marc J Berna; H R Alexander; Douglas L Fraker; Stephen K Libutti; Stephen J Marx; Fathia Gibril; Robert T Jensen
Journal:  Ann Surg       Date:  2008-03       Impact factor: 12.969

Review 6.  Hereditary hyperparathyroidism--a consensus report of the European Society of Endocrine Surgeons (ESES).

Authors:  Maurizio Iacobone; Bruno Carnaille; F Fausto Palazzo; Menno Vriens
Journal:  Langenbecks Arch Surg       Date:  2015-10-08       Impact factor: 3.445

7.  MEN1-associated primary hyperparathyroidism in the Spanish Registry: clinical characterictics and surgical outcomes.

Authors:  Cristina Lamas; Elena Navarro; Anna Casterás; Paloma Portillo; Victoria Alcázar; María Calatayud; Cristina Álvarez-Escolá; Julia Sastre; Evangelina Boix; Lluis Forga; Almudena Vicente; Josep Oriola; Jordi Mesa; Nuria Valdés
Journal:  Endocr Connect       Date:  2019-10       Impact factor: 3.335

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.